Please login to the form below

Not currently logged in
Email:
Password:

giant cell tumour of the bone

This page shows the latest giant cell tumour of the bone news and features for those working in and with pharma, biotech and healthcare.

FDA clears Amgen's Xgeva for rare bone condition

FDA clears Amgen's Xgeva for rare bone condition

US approval provides alternative to surgery for use in giant cell tumour of the bone. ... The US FDA yesterday gave a green to the use of Amgen's Xgeva (denosumab) to treat adults and some adolescents with giant cell tumour of the bone (GCTB).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...